Keytruda volumes by indication

The request was successful.

Dear Kingston Hospital NHS Foundation Trust,

What volume of Keytruda (Pembrolizumab) is used for each of the following indications:

Lung Cancer, Renal Cell Carcinoma, Urothelial, melanoma head and neck.

I look forward to your response.

Yours faithfully,

BEN HOLDSWORTH

Foienquiries (KINGSTON HOSPITAL NHS FOUNDATION TRUST), Kingston Hospital NHS Foundation Trust

Thank you for your request for information under the Freedom of
Information Act 2000. This is an acknowledgement of your request. For the
purposes of the Act, your request will be deemed to have been received on
the first working day following delivery. We will reply to your request by
the 20th working day following receipt.

COVID-19

Your request for information may be delayed due to urgent operational
responses to dealing with Public Health priorities. We apologise for any
inconvenience this may cause, we do remain committed to responding to your
request and will respond as soon as we are able. Should our response to
your request breach the statutory timeframe and you remain unhappy with
our response you have the right to complain to the Information
Commissioners Office and you can contact them at
[1]https://ico.org.uk/make-a-complaint/.

 

With kindest regards Kingston Hospital FOI.

show quoted sections

SORRELL, Janice (KINGSTON HOSPITAL NHS FOUNDATION TRUST), Kingston Hospital NHS Foundation Trust

1 Attachment

Dear Mr Holdsworth

 

Attached please find the Trusts reply to your Freedom of Information
request.

 

Kindest regards        Janice

Ms Janice Sorrell
Head of Information Governance
Kingston Hospital NHS Foundation Trust
 
Tel: 020 8973 5292
Email: [1][email address]
 

show quoted sections